PDS Biotechnology Stock Forward View - Triple Exponential Smoothing
| PDSB Stock | USD 0.69 0.01 1.50% |
PDS Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast PDS Biotechnology stock prices and determine the direction of PDS Biotechnology Corp's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of PDS Biotechnology's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of PDS Biotechnology's share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.18) | EPS Estimate Current Year (0.80) | EPS Estimate Next Year (0.68) | Wall Street Target Price 7.5 | EPS Estimate Current Quarter (0.17) |
Using PDS Biotechnology hype-based prediction, you can estimate the value of PDS Biotechnology Corp from the perspective of PDS Biotechnology response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards PDS Biotechnology using PDS Biotechnology's stock options and short interest. It helps to benchmark the overall future attitude of investors towards PDS using crowd psychology based on the activity and movement of PDS Biotechnology's stock price.
PDS Biotechnology Implied Volatility | 0.93 |
PDS Biotechnology's implied volatility exposes the market's sentiment of PDS Biotechnology Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if PDS Biotechnology's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that PDS Biotechnology stock will not fluctuate a lot when PDS Biotechnology's options are near their expiration.
The Triple Exponential Smoothing forecasted value of PDS Biotechnology Corp on the next trading day is expected to be 0.69 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 2.03. PDS Biotechnology after-hype prediction price | USD 0.68 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of PDS Biotechnology to cross-verify your projections. Open Interest Against 2026-05-15 PDS Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast PDS Biotechnology's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in PDS Biotechnology's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for PDS Biotechnology stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current PDS Biotechnology's open interest, investors have to compare it to PDS Biotechnology's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of PDS Biotechnology is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in PDS. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
PDS Biotechnology Additional Predictive Modules
Most predictive techniques to examine PDS price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PDS using various technical indicators. When you analyze PDS charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
PDS Biotechnology Triple Exponential Smoothing Price Forecast For the 14th of February 2026
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of PDS Biotechnology Corp on the next trading day is expected to be 0.69 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 2.03.Please note that although there have been many attempts to predict PDS Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that PDS Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
PDS Biotechnology Stock Forecast Pattern
| Backtest PDS Biotechnology | PDS Biotechnology Price Prediction | Research Analysis |
PDS Biotechnology Forecasted Value
In the context of forecasting PDS Biotechnology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. PDS Biotechnology's downside and upside margins for the forecasting period are 0.01 and 5.67, respectively. We have considered PDS Biotechnology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of PDS Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent PDS Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.0067 |
| MAD | Mean absolute deviation | 0.0344 |
| MAPE | Mean absolute percentage error | 0.0397 |
| SAE | Sum of the absolute errors | 2.0296 |
Predictive Modules for PDS Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PDS Biotechnology Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PDS Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PDS Biotechnology After-Hype Price Density Analysis
As far as predicting the price of PDS Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PDS Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of PDS Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
PDS Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting PDS Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PDS Biotechnology's historical news coverage. PDS Biotechnology's after-hype downside and upside margins for the prediction period are 0.03 and 5.66, respectively. We have considered PDS Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
PDS Biotechnology is very risky at this time. Analysis and calculation of next after-hype price of PDS Biotechnology Corp is based on 3 months time horizon.
PDS Biotechnology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as PDS Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PDS Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PDS Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.11 | 4.98 | 0.00 | 0.01 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.69 | 0.68 | 0.00 |
|
PDS Biotechnology Hype Timeline
PDS Biotechnology Corp is at this time traded for 0.69. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. PDS is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.11%. %. The volatility of related hype on PDS Biotechnology is about 6000.0%, with the expected price after the next announcement by competition of 0.68. The book value of the company was at this time reported as 0.2. The company recorded a loss per share of 0.81. PDS Biotechnology Corp last dividend was issued on the 18th of March 2019. The entity had 1:20 split on the 18th of March 2019. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Historical Fundamental Analysis of PDS Biotechnology to cross-verify your projections.PDS Biotechnology Related Hype Analysis
Having access to credible news sources related to PDS Biotechnology's direct competition is more important than ever and may enhance your ability to predict PDS Biotechnology's future price movements. Getting to know how PDS Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PDS Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ATNM | Actinium Pharmaceuticals | (0.02) | 8 per month | 0.00 | (0.05) | 5.84 | (5.43) | 20.75 | |
| XLO | Xilio Development | 0.00 | 6 per month | 0.00 | (0.15) | 4.23 | (5.56) | 15.41 | |
| LVTX | LAVA Therapeutics NV | 0.01 | 6 per month | 1.19 | 0.05 | 4.70 | (2.63) | 14.75 | |
| OKUR | OnKure Therapeutics | 0.08 | 5 per month | 0.00 | (0.06) | 7.76 | (6.92) | 25.44 | |
| TPST | Tempest Therapeutics | (0.05) | 8 per month | 0.00 | (0.20) | 7.62 | (9.56) | 52.01 | |
| KZR | Kezar Life Sciences | 0.05 | 7 per month | 1.00 | (0.01) | 1.60 | (1.27) | 7.79 | |
| FGEN | FibroGen | (0.96) | 7 per month | 0.00 | (0.07) | 4.33 | (5.28) | 28.75 | |
| RVPH | Reviva Pharmaceuticals Holdings | (0.01) | 8 per month | 0.00 | (0.08) | 10.71 | (9.68) | 57.05 | |
| ANVS | Annovis Bio | (0.02) | 9 per month | 5.13 | 0.06 | 14.79 | (9.57) | 41.06 | |
| INMB | INmune Bio | 0.09 | 6 per month | 0.00 | (0.03) | 6.82 | (7.51) | 22.66 |
Other Forecasting Options for PDS Biotechnology
For every potential investor in PDS, whether a beginner or expert, PDS Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. PDS Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in PDS. Basic forecasting techniques help filter out the noise by identifying PDS Biotechnology's price trends.PDS Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PDS Biotechnology stock to make a market-neutral strategy. Peer analysis of PDS Biotechnology could also be used in its relative valuation, which is a method of valuing PDS Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
PDS Biotechnology Market Strength Events
Market strength indicators help investors to evaluate how PDS Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PDS Biotechnology shares will generate the highest return on investment. By undertsting and applying PDS Biotechnology stock market strength indicators, traders can identify PDS Biotechnology Corp entry and exit signals to maximize returns.
PDS Biotechnology Risk Indicators
The analysis of PDS Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in PDS Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pds stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.13 | |||
| Standard Deviation | 5.35 | |||
| Variance | 28.64 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for PDS Biotechnology
The number of cover stories for PDS Biotechnology depends on current market conditions and PDS Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PDS Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PDS Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
PDS Biotechnology Short Properties
PDS Biotechnology's future price predictability will typically decrease when PDS Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of PDS Biotechnology Corp often depends not only on the future outlook of the potential PDS Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PDS Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.5 M | |
| Cash And Short Term Investments | 41.7 M |
Check out Historical Fundamental Analysis of PDS Biotechnology to cross-verify your projections. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. Anticipated expansion of PDS directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive PDS Biotechnology assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate PDS Biotechnology Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating PDS Biotechnology's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause PDS Biotechnology's market price to deviate significantly from intrinsic value.
It's important to distinguish between PDS Biotechnology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PDS Biotechnology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, PDS Biotechnology's market price signifies the transaction level at which participants voluntarily complete trades.